![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_5ad4815e35d60b329cae6d66fd9bd103.svg) | Lixivaptan | IC50 | 1.0 [1], 1.2 [2], 5.0 [3], 91.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_5ad4815e35d60b329cae6d66fd9bd103.svg) | Lixivaptan | Ki | 2.3 [1], 23.0 [2], 90.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_105aa90f970fa13d88993e59627fb373.svg) | Argipressin | IC50 | 242.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_105aa90f970fa13d88993e59627fb373.svg) | Argipressin | Ki | 1.2 [1], 1.36 [2], 1.48 [3], 32.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_6555f8456ca360ce480ce44d5768160e.svg) | Way-vna-932 | IC50 | 80.0 [1], 80.3 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_6555f8456ca360ce480ce44d5768160e.svg) | Way-vna-932 | Ki | 39.9 [1], 50.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_f03f292fb8b0223e423ee0f158ebf219.svg) | 2-Phenyl-4'-[(2,3,4,5-tetrahydro-1H-1-benzoazepine-1-yl)carbonyl]benzanilide | IC50 | 0.57 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_f03f292fb8b0223e423ee0f158ebf219.svg) | 2-Phenyl-4'-[(2,3,4,5-tetrahydro-1H-1-benzoazepine-1-yl)carbonyl]benzanilide | Ki | 0.57 [1], 7.5 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_0ae387d35d06fa8ada3a04e3347824bf.svg) | Cligosiban | IC50 | 1530.0 [1], 2620.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_0ae387d35d06fa8ada3a04e3347824bf.svg) | Cligosiban | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_103ae79e076b6a0d3526eba4591bc8b8.svg) | 2-(4-Fluoro-2-methylphenyl)-5-[4-(6-methoxypyridin-3-yl)-5-methyl-1,2,4-triazol-3-yl]pyrazine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_5f50c8ca469617361807e5b95f7510fb.svg) | 1-[4-[(5-Fluoro-2-methylbenzoyl)amino]benzoyl]-N-(2-piperidin-1-ylethyl)spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 8.0 [1], 9.0 [2], 39.0 [3], 48.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_d79c8cfb69d03d0c8e8a8d25f6089921.svg) | Oxytocin | Ki | 1544.0 [1], 3500.0 [2], 6000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_2016e1fb48c552930d228a3e7f6e1433.svg) | Quercetin | IC50 | 6309.57 [1], 15848.93 [2], 39810.72 [3] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_c75ccb7785680a70e6aeb3467096e4e0.svg) | Sporanox | IC50 | 794.33 [1], 6309.57 [2], 12589.25 [3] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_8d9e60a3506daae0fa255b11426ad535.svg) | Mozavaptan | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_8d9e60a3506daae0fa255b11426ad535.svg) | Mozavaptan | Ki | 9.42 [1], 9.7 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_2d998be0de07c472e5487de9f8ca97eb.svg) | 1-(1-(4-(3-Acetylaminopropoxy)benzoyl)-4-piperidyl)-3,4-dihydro-2(1H)-quinolinone | Ki | 10000.0 [1], 81000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_e7b5d1dbcd8bca66fa691528c317c84a.svg) | Nelivaptan | Ki | 290.0 [1], 325.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_2ec5b406f06395b49a4f718691cfe3ca.svg) | CID 6918320 | Ki | 37000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_6c5a78e8ca55529a3f6c3b506ecb26d6.svg) | Clotrimazole | IC50 | 2511.89 [1], 15848.93 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_19efefdeab332387353fa1fe7f841c53.svg) | Conivaptan | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_19efefdeab332387353fa1fe7f841c53.svg) | Conivaptan | Ki | 0.36 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_a76ebebdff841ac12c150f8e7642f86b.svg) | Unii-ER33G946JT | Ki | 590.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_0e105c002066e65b327b2b1c98239c53.svg) | CID 3038506 | IC50 | 330.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_0e105c002066e65b327b2b1c98239c53.svg) | CID 3038506 | Ki | 91.9 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_685c2cce11c0614c7c05937027f0b4c5.svg) | 4-[(3,5-Dihydroxyphenyl)methyl]-N-[[2-methyl-4-(1-methyl-4,10-dihydropyrazolo[4,3-c][1,5]benzodiazepine-5-carbonyl)phenyl]methyl]piperazine-1-carboxamide | Ki | 58.4 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_ab7265caf22ddec5763aac4d88df7363.svg) | Unii-4V7CN33O10 | IC50 | 34.0 [1], 52.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_9aaca1597c6458be1d3d1cad6cdd71d1.svg) | (2S)-2-(4-Methyl-1,4-diazepane-1-carbothioyl)-N-[[2-methyl-4-(1-methyl-4,10-dihydropyrazolo[4,3-c][1,5]benzodiazepine-5-carbonyl)phenyl]methyl]pyrrolidine-1-carboxamide | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_42810e6d5e00c17a080d066c5f201ed4.svg) | CID 6918854 | Ki | 630.96 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_7e23dc08956494dec4056867ed25d666.svg) | 1-[1-[2-[2-(2-Fluoroethoxy)-4-(1-methylsulfonylpiperidin-4-yl)oxyphenyl]acetyl]piperidin-4-yl]-3,4-dihydroquinolin-2-one | Ki | 1800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_9b323ef10cc01adb92a9a4a860ec27c3.svg) | (2-Chloro-4-pyrrolidin-1-yl-phenyl)-(2,3,4,5-tetrahydro-benzo[b]azepin-1-yl)-methanone | IC50 | 9.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_661558fa264427dccc553283dd12d03a.svg) | (2R)-2-[(2R,5R)-5-(2,3-Dihydro-1H-inden-2-yl)-2-(2-methylpropyl)-3,6-dioxopiperazin-1-yl]-2-(4-fluorophenyl)-N-propan-2-ylacetamide | Ki | 1258.93 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_a170d995ca7b1d86e02e8e00babea212.svg) | (2R)-2-[(2R,5R)-5-(2,3-Dihydro-1H-inden-2-yl)-2-(2-methylpropyl)-3,6-dioxopiperazin-1-yl]-2-[4-(dimethylamino)phenyl]-N-propan-2-ylacetamide | Ki | 79432.82 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_324231688bdc24d420d286a775ecc129.svg) | 2,4-Dichloro-N-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide | IC50 | 3.2 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_3f9ea5223f4f6a52f9b164c71ed69fd4.svg) | (4-Amino-2-methyl-phenyl)-(7-chloro-2,3,4,5-tetrahydro-benzo[b]azepin-1-yl)-methanone | IC50 | 4.1 [1], 18.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_deff751f10f7e7011510581ae98eeb52.svg) | 1H-1-Benzazepine, 1-(4-aminobenzoyl)-2,3,4,5-tetrahydro- | IC50 | 180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_deff751f10f7e7011510581ae98eeb52.svg) | 1H-1-Benzazepine, 1-(4-aminobenzoyl)-2,3,4,5-tetrahydro- | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_e8fa519ee4194c6904b912eaf39c892f.svg) | 2-(N-(4-Ethoxyphenyl)sulfonyl-4-methylanilino)-N-[(2-hydroxy-1H-indol-3-yl)imino]acetamide | Ki | 2500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_3f984a541bdf76eecdf08400c956a8e1.svg) | (2R)-2-(2,4-Difluorophenyl)-2-[(2R,5R)-5-(2,3-dihydro-1H-inden-2-yl)-2-(2-methylpropyl)-3,6-dioxopiperazin-1-yl]-N,N-dimethylacetamide | Ki | 39.81 [1], 316.23 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_cced0d1a900b96b238c6f54cbb5017f6.svg) | 1-[4-(2-Methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine | Ki | 2.68 [1], 7.2 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_3dbd589f5dc606fc50bec7ad0ead8130.svg) | [2-Chloro-4-(3-methylpyrazol-1-yl)phenyl]-(1-methyl-4,10-dihydropyrazolo[4,3-c][1,5]benzodiazepin-5-yl)methanone | Ki | 29.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_924517a5ad86596fef7d198b9348cf88.svg) | (2Z)-2-[1-[2-Chloro-4-(3-methylpyrazol-1-yl)benzoyl]-4,4-difluoro-2,3-dihydro-1-benzazepin-5-ylidene]-N-(2-hydroxyethyl)acetamide | Ki | 9.7 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_0d2e5cbee1aa0280b134c551bdcd96c9.svg) | 5-[3-(Ethoxymethyl)-5-(4-ethoxy-3-methylphenyl)-1,2,4-triazol-4-yl]-2-methoxypyridine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_6fb2146fc3c559df9e0dfdb27e43f326.svg) | N-[4-[(12S)-6-Chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]-2-(trifluoromethyl)benzamide | IC50 | 7.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_6fb2146fc3c559df9e0dfdb27e43f326.svg) | N-[4-[(12S)-6-Chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]-2-(trifluoromethyl)benzamide | Ki | 9.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_eefaa1534726199243fb9f1069f91cd3.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]thiazino[3,4-c][1,4]benzodiazepine-6-carbonyl]phenyl]-2-phenylbenzamide | Ki | 3.2 [1], 15.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_cb98e70dbfad34002618575f4c20a888.svg) | N-[2-(Dimethylamino)ethyl]-1-[4-[(2-phenylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 11.0 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_311fcc0362112bf0db13920808d07b59.svg) | (4R)-1-[4-[(2-Chloro-5-fluorobenzoyl)amino]-3-ethoxybenzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxylic acid | IC50 | 71.0 [1], 150.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_d8c5fab2f16f3a27dcee29542ba3d5bd.svg) | 1-[4-[(2-Chloro-5-fluorobenzoyl)amino]-3-methoxybenzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxylic acid | IC50 | 92.0 [1], 120.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_7b58515a70cd6ab72bd82cfb4663bc25.svg) | (4R)-1-[4-[(2-Chloro-5-fluorobenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxylic acid | IC50 | 53.0 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_f7a3f7c0f51b83fd915d583bb550e263.svg) | N-[3-Chloro-4-[(12R)-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4,6,8-triene-10-carbonyl]phenyl]-2-phenylbenzamide | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_f7a3f7c0f51b83fd915d583bb550e263.svg) | N-[3-Chloro-4-[(12R)-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4,6,8-triene-10-carbonyl]phenyl]-2-phenylbenzamide | Ki | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_b0b21009d7dcc44ced104e74c7f63ea7.svg) | (10R,13S,16S,19S)-N-[(2S)-1-[[(2R)-1-Amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-19-(2-amino-2-oxoethyl)-13-benzyl-10-[(4-ethoxyphenyl)methyl]-8,11,14,17,20-pentaoxo-16-propan-2-yl-9,12,15,18,21-pentazaspiro[5.19]pentacosane-22-carboxamide | Ki | 400000.0 [1], 3900000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_3fcf37fdb85069f388fb021bad597ae3.svg) | N-[3-Chloro-4-(2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]-3-methylpyrazole-1-carboxamide | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_3fcf37fdb85069f388fb021bad597ae3.svg) | N-[3-Chloro-4-(2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]-3-methylpyrazole-1-carboxamide | Ki | 38.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_e81637db2b08992006232e6b283af44a.svg) | 1-[4-[(2-Phenylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxylic acid | IC50 | 14.0 [1], 360.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_fd240d8b0186a65334c6cc7c2d1e9d56.svg) | 1-[4-[(5-Fluoro-2-methylbenzoyl)amino]-2-methoxybenzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxylic acid | IC50 | 110.0 [1], 140.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_fe09bae5018ba0028bf7b81850957521.svg) | 1-[4-[(5-Fluoro-2-methylbenzoyl)amino]benzoyl]-N-(2-pyrrolidin-1-ylethyl)spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 39.0 [1], 48.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_25ceba880fa4fb4c5d4a197d3e32c32e.svg) | N-[4-[1'-(Hydroxymethyl)spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1-carbonyl]phenyl]-2-phenylbenzamide | IC50 | 18.0 [1], 190.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_3b8cc71a8374e15e4bee19b2cf66e371.svg) | N-[4-[1'-(Methylaminomethyl)spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1-carbonyl]phenyl]-2-phenylbenzamide | IC50 | 44.0 [1], 1800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_450db5457745a4037ab98fa1e11dd093.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]phenyl]-2-phenylbenzamide | Ki | 3.7 [1], 16.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_7182f4149d55dc0bad87751e19af12e7.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-5-fluoro-2-methylbenzamide | Ki | 2.8 [1], 12.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_8473fb416ed8ff14f496f2918e56d951.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-4-fluoro-2-phenylbenzamide | Ki | 1.9 [1], 2.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_25dc90b4808e9c2d199a36913886991a.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-4-methoxy-2-phenylbenzamide | Ki | 4.2 [1], 5.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_89a8de38ce752604473c44418f011246.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-5-fluoro-2-phenylbenzamide | Ki | 11.0 [1], 12.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_6bf2645645bea8f28c74dffd132abdad.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-(4-hydroxyphenyl)benzamide | Ki | 4.2 [1], 11.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_668637f8fd3cc9ecfe34b47b112dd311.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-(3-hydroxyphenyl)benzamide | Ki | 5.0 [1], 20.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_44957c8bece237ee996141724cbbb18d.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-(4-methoxyphenyl)benzamide | Ki | 2.8 [1], 3.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_ffd10a0856078ffc8a36ddedd490409b.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-(3-methoxyphenyl)benzamide | Ki | 2.0 [1], 3.7 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_2c028a150b8f587049187f9d46452935.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-4-hydroxy-2-phenylbenzamide | Ki | 1.4 [1], 6.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_de03b641063db6dce4f2a9f857ce09ce.svg) | N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-5-hydroxy-2-phenylbenzamide | Ki | 13.0 [1], 70.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_4c0c6459bae342df1dcb12bcff1f8c12.svg) | N-[4-(8-Methyl-1,2,4,4a,5,11-hexahydro-[1,4]thiazino[3,4-c][1,4]benzodiazepine-6-carbonyl)phenyl]-2-phenylbenzamide | Ki | 8.0 [1], 23.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_2c02128f13253c4613c350eb894bee70.svg) | N-[4-[(4Ar)-1,2,4,4a,5,11-hexahydro-[1,4]thiazino[3,4-c][1,4]benzodiazepine-6-carbonyl]phenyl]-2-phenylbenzamide | Ki | 25.0 [1], 40.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_690eec15b999404e227e5f3e7501fffd.svg) | N-[4-(3,3-Dioxo-1,2,4,4a,5,11-hexahydro-[1,4]thiazino[3,4-c][1,4]benzodiazepine-6-carbonyl)phenyl]-2-phenylbenzamide | Ki | 40.0 [1], 65.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_de3c160c30b8be774edae9538fcf14ed.svg) | N-[4-(1,2,4,4a,5,11-Hexahydro-[1,4]thiazino[3,4-c][1,4]benzodiazepine-6-carbonyl)-3-chlorophenyl]-5-fluoro-2-phenylbenzamide | Ki | 37.0 [1], 70.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_7aa646aa80ec5564ea48acb3ffcabde4.svg) | N-[4-(1,2,4,4a,5,11-Hexahydro-[1,4]thiazino[3,4-c][1,4]benzodiazepine-6-carbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide | Ki | 60.0 [1], 300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_bc1e15db00e682ded8bc829721a2aba3.svg) | N-[4-[(12S)-6-Chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]-2-(4-methylphenyl)benzamide | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_bc1e15db00e682ded8bc829721a2aba3.svg) | N-[4-[(12S)-6-Chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]-2-(4-methylphenyl)benzamide | Ki | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_80e82b1691885ecf919d4fbda5f36479.svg) | 2-Chloro-N-[4-[(12S)-6-chloro-2,10-diazatetracyclo[11.2.2.02,12.04,9]heptadeca-4(9),5,7-triene-10-carbonyl]phenyl]benzamide | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_80e82b1691885ecf919d4fbda5f36479.svg) | 2-Chloro-N-[4-[(12S)-6-chloro-2,10-diazatetracyclo[11.2.2.02,12.04,9]heptadeca-4(9),5,7-triene-10-carbonyl]phenyl]benzamide | Ki | 520.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_5124d0aac92d6b4a3066d571923acfbf.svg) | 2-Chloro-N-[4-[(12S)-6-chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]benzamide | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_5124d0aac92d6b4a3066d571923acfbf.svg) | 2-Chloro-N-[4-[(12S)-6-chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]benzamide | Ki | 32.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_2efd940845f068c771d1c7ea2113e86f.svg) | 2-Methyl-N-[4-(1,2,3,4-tetrahydro-1,5-benzodiazepine-5-carbonyl)phenyl]benzamide | IC50 | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_2efd940845f068c771d1c7ea2113e86f.svg) | 2-Methyl-N-[4-(1,2,3,4-tetrahydro-1,5-benzodiazepine-5-carbonyl)phenyl]benzamide | Ki | 160.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_ac6e0564aff63e19db2f76c2680a0a36.svg) | N-[4-[(12S)-6-Chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]-2-fluorobenzamide | IC50 | 26.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_ac6e0564aff63e19db2f76c2680a0a36.svg) | N-[4-[(12S)-6-Chloro-2,10-diazatetracyclo[11.2.1.02,12.04,9]hexadeca-4(9),5,7-triene-10-carbonyl]phenyl]-2-fluorobenzamide | Ki | 180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_bd10a8dc3976733a97c299f8109d6d1a.svg) | N-[3-(Dimethylamino)propyl]-1-[4-[(5-fluoro-2-methylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 23.0 [1], 31.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_9e58747a49e8686a654b30ae75542aee.svg) | 1-[4-[(2-Fluorobenzoyl)amino]benzoyl]-N-(2-piperidin-1-ylethyl)spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_dfc52ba326933cfd196b1a7191e6f5d3.svg) | 1-[4-[(2-Fluorobenzoyl)amino]benzoyl]-N-(2-pyrrolidin-1-ylethyl)spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_d403e22dd39d9e1a1e35df86718fe7f5.svg) | N-[2-(Dimethylamino)ethyl]-1-[4-[(5-fluoro-2-methylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 20.0 [1], 105.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_15a3383bfb3ad22b1dde09aa7d348c09.svg) | Methyl 2-[[1-[4-[(5-fluoro-2-methylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carbonyl]amino]acetate | IC50 | 10.0 [1], 440.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_9bcd12aaacb5f5b14bfe9b5f52e74df4.svg) | N-(2-Hydroxyethyl)-1-[4-[(2-phenylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 11.0 [1], 170.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_46050eebd086eb7f1229d569a96f74dc.svg) | 2-[[1-[4-[(2-Phenylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carbonyl]amino]acetic acid | IC50 | 18.0 [1], 350.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_1e3188954c5200491b0a46b70171b80f.svg) | N-[3-(Dimethylamino)propyl]-1-[4-[(2-phenylbenzoyl)amino]benzoyl]spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 16.0 [1], 20.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_415922c529092114a39219123199aa90.svg) | 1-[4-[(2-Fluorobenzoyl)amino]benzoyl]-N-(2-hydroxyethyl)spiro[3,5-dihydro-2H-1-benzazepine-4,3'-cyclopentene]-1'-carboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_0dd99c0480444bda370124e011ee169d.svg) | 2-[(2R)-5-[4-[(2-Phenylbenzoyl)amino]benzoyl]-3,4-dihydro-2H-1,5-benzothiazepin-2-yl]acetic acid | IC50 | 7.0 [1], 36.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_1ded7727822dfc526080f7909e7605a5.svg) | 3-[(2R)-5-[4-[(2-Phenylbenzoyl)amino]benzoyl]-3,4-dihydro-2H-1,5-benzothiazepin-2-yl]propanoic acid | IC50 | 16.0 [1], 40.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_58b32abb2088d82ddcfe6455aa0191bb.svg) | N-[4-[2-(2-Hydroxyethyl)-3,4-dihydro-2H-1,5-benzothiazepine-5-carbonyl]phenyl]-2-phenylbenzamide | IC50 | 8.0 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vasopressin-v2-receptor_ba4e005f594c65c27fc91a324712f64e.svg) | 3-[(2S)-5-[4-[(2-Phenylbenzoyl)amino]benzoyl]-3,4-dihydro-2H-1,5-benzothiazepin-2-yl]propanoic acid | IC50 | 15.0 [1], 30.0 [2] |